There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Teladoc Health Inc. (TDOC) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.82, or -2.78%, to $28.63. Volume reached 86,593 shares, with price reaching a high of $29.1 and a low of $28.55. Recently, Yahoo Finance discussed the stock, revealing that Cloud DX Presents at VirtualInvestorConferences.com on September 15th.
This NYSE-listed company operates within the Health Information Services industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $28.84 and fluctuated between $30.60 as its day high and $28.81 as its day low. The current market capitalization of Teladoc Health Inc. is $4.88B. A total of 3.81 million shares were traded on the day, compared to an average of 5.08M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, TDOC has seen 1 BUY and 3 SELL insider trades, representing the acquisition of 7,968 and the disposition of 6,053 shares. Over the last 12 months, there were 60 BUYs and 32 SELLs from insiders. Insiders purchased 190,692 shares during that period but sold 81,490.
In the most recent transaction, Trencher Daniel sold 1,000 shares of TDOC for 30.18 per share on Sep 19. After the transaction, the SVP CORPORATE STRATEGY now owns 25,408 company shares. In a previous transaction on Aug 26, Geshuri Arnnon sold 4,098 shares at 34.27 per share. TDOC shares that CHIEF PEOPLE OFFICER owns now total 76,182.
Among the insiders who sold shares, Trencher Daniel disposed of 1,000 shares on Aug 17 at a per-share price of $37.50. This resulted in the SVP CORPORATE STRATEGY holding 26,408 shares of TDOC after the transaction. In another insider transaction, Trencher Daniel sold 1,000 shares at $41.12 per share on Jul 18. Company shares held by the SVP CORPORATE STRATEGY now total 27,408.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for TDOC in the last 3 months, the mean price target is $36.65 with high estimates of $55.00 and low estimates of $25.00. In terms of 52-week highs and lows, TDOC has a high of $156.82 and a low of $27.38.
As of this writing, TDOC has an earnings estimate of $-0.58 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $-0.44 per share and a lower estimate of $-0.77. The company reported an EPS of $-0.44 in the last quarter, which was 38.03% higher than expectations of $-0.71.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. TDOC’s latest balance sheet shows that the firm has $896.02M in Cash & Short Term Investments as of fiscal 2021. There were $1.28B in debt and $331.01M in liabilities at the time. Its Book Value Per Share was $37.70, while its Total Shareholder’s Equity was $16.05B.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 32 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TDOC is Sell with a score of 3.29. A total of 5 analysts rated the stock as Buy while 0 rated it as Overweight while 26 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.